Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,499 | -26,129 | -25,781 | -23,460 | -25,997 |
| Depreciation Amortization | 1,015 | 312 | 374 | 439 | 542 |
| Accounts receivable | -55 | 15 | 27 | -52 | 0 |
| Accounts payable and accrued liabilities | -223 | 267 | 61 | -225 | 368 |
| Other Working Capital | -1,767 | 113 | 1,018 | -3,684 | 2,626 |
| Other Operating Activity | 3,922 | 6,037 | 5,876 | 4,503 | 2,526 |
| Operating Cash Flow | $-22,606 | $-19,384 | $-18,426 | $-22,479 | $-19,935 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,000 | -1,008 |
| PPE Investments | -39 | -89 | -416 | -76 | -252 |
| Other Investing Activity | 0 | 0 | 200 | 0 | 6,327 |
| Investing Cash Flow | $-39 | $-89 | $-216 | $924 | $5,067 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,500 | N/A | N/A | 5,348 | N/A |
| Common Stock Issued | 22,652 | 12,079 | 24,079 | 11,200 | 14,652 |
| Other Financing Activity | -5,199 | -4,285 | -4,448 | -1,171 | -2,136 |
| Financing Cash Flow | $18,953 | $7,794 | $19,630 | $15,377 | $12,516 |
| Beginning Cash Position | 11,619 | 23,298 | 22,309 | 28,488 | 30,841 |
| End Cash Position | 7,927 | 11,619 | 23,298 | 22,309 | 28,488 |
| Net Cash Flow | $-3,692 | $-11,678 | $989 | $-6,179 | $-2,353 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,606 | -19,384 | -18,426 | -22,479 | -19,935 |
| Capital Expenditure | -39 | -89 | -416 | -76 | -252 |
| Free Cash Flow | -22,645 | -19,472 | -18,842 | -22,556 | -20,188 |